AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
-5.2%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$176M
AUM Growth
+$176M
(-2.2%)
Cap. Flow
+$6.06M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
22.12%
Holding
256
New
24
Increased
39
Reduced
132
Closed
21
Top Buys
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
$3.22M |
| 2 |
uniQure
QURE
|
$2.31M |
| 3 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$2.18M |
| 4 |
TSVT
2seventy bio
TSVT
|
$1.87M |
| 5 |
Embecta
EMBC
|
$1.71M |
Top Sells
| 1 |
AdaptHealth
AHCO
|
$3.44M |
| 2 |
Elanco Animal Health
ELAN
|
$2.97M |
| 3 |
Centene
CNC
|
$2.7M |
| 4 |
iShares MBS ETF
MBB
|
$2.05M |
| 5 |
Lantheus
LNTH
|
$1.93M |
Sector Composition
| 1 | Healthcare | 61.76% |
| 2 | Real Estate | 10.3% |
| 3 | Financials | 3.56% |
| 4 | Technology | 3.07% |
| 5 | Energy | 2.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Collegium Pharmaceutical
COLL
$1.23B
| $1.11M | 0.63% |
49,500
| – | – |
|
52
Intuitive Surgical
ISRG
$168B
| $1.1M | 0.62% |
3,750
-1,250
| -25% | -$365K |
|
53
Ultragenyx Pharmaceutical
RARE
$3.09B
| $1.07M | 0.61% |
30,000
+1,500
| +5% | +$53.5K |
|
|
RWT
54
Redwood Trust
RWT
$773M
| $1.05M | 0.59% |
146,593
| – | – |
|
55
Acadia Pharmaceuticals
ACAD
$4.33B
| $1.04M | 0.59% |
50,000
| – | – |
|
|
PETQ
56
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.02M | 0.58% |
52,000
-43,000
| -45% | -$847K |
|
57
AeroVironment
AVAV
$12B
| $1M | 0.57% |
9,000
-1,000
| -10% | -$112K |
|
|
IMGN
58
DELISTED
Immunogen Inc
IMGN
| $992K | 0.56% |
+62,500
| New | +$992K |
|
59
Procept Biorobotics
PRCT
$2.2B
| $984K | 0.56% |
30,000
-20,000
| -40% | -$656K |
|
60
Synopsys
SNPS
$110B
| $964K | 0.55% |
2,100
-400
| -16% | -$184K |
|
61
ADC Therapeutics
ADCT
$349M
| $958K | 0.54% |
1,068,468
+290,468
| +37% | +$261K |
|
62
Accuray
ARAY
$153M
| $952K | 0.54% |
350,000
| – | – |
|
63
Stereotaxis
STXS
$246M
| $948K | 0.54% |
600,000
+50,000
| +9% | +$79K |
|
64
Allient
ALNT
$766M
| $928K | 0.53% |
30,000
| – | – |
|
|
VRNA
65
Verona Pharma
VRNA
$9.18B
| $913K | 0.52% |
56,000
+1,000
| +2% | +$16.3K |
|
66
scPharmaceuticals
SCPH
$296M
| $890K | 0.5% |
+125,000
| New | +$890K |
|
67
Arcutis Biotherapeutics
ARQT
$1.84B
| $876K | 0.5% |
165,000
-127,500
| -44% | -$677K |
|
68
Symbotic
SYM
$5.07B
| $836K | 0.47% |
25,000
| – | – |
|
69
Mobileye
MBLY
$11.2B
| $831K | 0.47% |
20,000
-5,000
| -20% | -$208K |
|
70
AGNC Investment
AGNC
$10.2B
| $799K | 0.45% |
84,646
-40,000
| -32% | -$378K |
|
71
Teradyne
TER
$19.2B
| $753K | 0.43% |
+7,500
| New | +$753K |
|
|
ONIT
72
Onity Group Inc.
ONIT
$335M
| $730K | 0.41% |
28,195
| – | – |
|
73
Protagonist Therapeutics
PTGX
$3.66B
| $726K | 0.41% |
+43,500
| New | +$726K |
|
74
Omnicell
OMCL
$1.47B
| $676K | 0.38% |
15,000
| – | – |
|
75
Helix Energy Solutions
HLX
$960M
| $670K | 0.38% |
+60,000
| New | +$670K |
|